MCK vs CVS vs CAH Stock Comparison

Mckesson, Cvs Health and Cardinal Health Prices as of Nov 13, 2026 Peers: Industry group
1 more company in this comparison (COR) Create a free account to keep reading and compare up to 10 companies.
MCK Mckesson Corp
$1,102.82 +12.7% 1M +30.3% 1Y
Market cap
$128.85B
P/E
27.4x
Revenue (TTM)
$418.79B
Div. yield
0.00%
Drug Distribution Healthcare
3 wins
CVS CVS HEALTH Corp
$89.33 -1.2% 1M +12.7% 1Y
Market cap
$113.39B
P/E
10.3x
Revenue (TTM)
$420.61B
Div. yield
–
Managed Care Healthcare
4 wins
CAH Cardinal Health Inc
$281.08 +13.4% 1M +36.4% 1Y
Market cap
$65.94B
P/E
36.3x
Revenue (TTM)
$257.75B
Div. yield
0.01%
Drug Distribution Healthcare
5 wins

Head to Head

12 decided of 12

Cardinal Health leads on 5 of the 12 questions below (Cardinal Health 5, Cvs Health 4, Mckesson 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKCVSCAHLeader
Larger companyMarket capitalisation $128.85B $113.39B $65.94B MCK
Cheaper on earningsLower P/E, profitable companies only 27.4x 10.3x 36.3x CVS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.8x 10.2x 22.8x CVS
Faster revenue growthRevenue growth, trailing twelve months +8.2% +6.7% +10.0% CAH
More profitableNet margin, trailing twelve months 1.1% 2.6% 0.7% CVS
Better return on capitalReturn on invested capital 98.7% 9.7% 36.5% MCK
Less leveragedLower net debt / EBITDA 0.4x 2.3x 1.0x MCK
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% CAH
Better 1-year returnPrice return, last 12 months +30.3% +12.7% +36.4% CAH
Better 5-year returnAnnualised price return, 5 years +37.5%/yr -1.0%/yr +40.5%/yr CAH
Less volatileAnnualised volatility, 1 year 31.4% 35.1% 25.9% CAH
Higher overall scoreMean of the five percentile scores vs peers 58/100 72/100 60/100 CVS

Percentile Scorecard

MCKCVSCAH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKCVSCAH
Valuation 65 #10 of 27 100 #1 of 27 77 #7 of 27
Growth 56 #12 of 26 80 #6 of 26 68 #9 of 26
Profitability 56 #12 of 26 84 #5 of 26 60 #11 of 26
Financial Health 56 #12 of 26 24 #20 of 26 40 #16 of 26
Shareholder Returns 59 #8 of 18 71 #6 of 18 53 #9 of 18
Overall 58 72 60
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • CVS ranked among 27 companies in Healthcare Payers and Distributors
  • CAH ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKCVSCAHSPY
1 month +12.7%-1.2%+13.4% -2.0%
3 months +26.9%-8.1%+19.5% -2.8%
6 months +45.0%-6.8%+44.0% +2.0%
Year to date +34.4%+12.6%+36.8% +10.6%
1 year +30.3%+12.7%+36.4% +12.2%
3 years +143.0%+30.4%+173.2% +68.1%
3 years, per year +34.5%+9.3%+39.8% +18.9%
5 years +390.5%-5.0%+446.4% +61.4%
5 years, per year +37.5%-1.0%+40.5% +10.1%
10 years +671.0%+19.0%+293.8% +248.5%
10 years, per year +22.7%+1.8%+14.7% +13.3%

Risk

MeasureMCKCVSCAHSPY
Volatility, 1Y 31.4%35.1%25.9% 13.6%
Downside volatility, 1Y 27.2%38.8%24.8% 13.9%
Beta vs S&P 500, 1Y -0.18-0.05-0.01 1.00
Return / volatility, 1Y 0.970.361.41 0.90
Max drawdown, 5Y -27.2%-60.5%-21.0% -25.4%
From 52-week high 0.0%-19.2%0.0% -3.2%
52-week high $1,102.82$110.55$281.08 $779.14
52-week low $725.17$70.08$182.50 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKCVSCAH
P/E now vs peer median 27.3xmedian 25.2x 10.4xmedian 25.2x 35.9xmedian 25.2x
P/S now vs peer median 0.3xmedian 0.4x 0.3xmedian 0.4x 0.3xmedian 0.4x
EV/EBITDA now vs peer median 17.4xmedian 14.5x 8.2xmedian 14.5x 18.7xmedian 14.5x
P/FCF now vs peer median 17.9xmedian 16.5x 7.3xmedian 16.5x 13.3xmedian 16.5x
P/B now vs peer median -32.2xmedian 2.7x 1.4xmedian 2.7x -21.5xmedian 2.7x
PEG now vs peer median 1.72median 1.72 1.22median 1.72 0.40median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKCVSCAH
Revenue $418.79B $420.61B $257.75B
Gross profit $15.37B $186.06B $10.05B
Operating income $6.69B $15.06B $2.70B
Net income $5.43B $11.09B $1.82B
Free cash flow $7.11B $15.57B $4.90B
EPS (diluted) $40.27 $8.55 $7.80
Cash & equivalents $6.53B $11.74B $5.26B
Total debt $9.21B $60.68B $8.82B
Shares (diluted) 116.70M 1.29B 233.00M
Enterprise value $110.22B $62.15B $49.11B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKCVSCAH
P/E 27.3x 10.4x 35.9x
P/FCF 17.9x 7.3x 13.3x
P/Operating cash flow 17.0x 6.1x 11.6x
P/S 0.3x 0.3x 0.3x
P/B -32.2x 1.4x -21.5x
P/Tangible book -16.1x 2.0x -21.5x
EV/EBITDA 17.4x 8.2x 18.7x
EV/EBIT 19.4x 10.6x 25.4x
EV/Revenue 0.3x 0.4x 0.3x
EV/FCF 18.3x 10.3x 14.0x
EV/Operating cash flow 17.3x 8.6x 12.2x
PEG (3Y EPS CAGR) 1.72 1.22 0.40

Growth

14 metrics
MetricMCKCVSCAH
Revenue growth (1Y) 8.2% 6.7% 10.0%
Revenue CAGR (3Y) 12.9% 6.5% 7.1%
Gross profit growth (1Y) 11.8% 5.3% 17.1%
Gross profit CAGR (3Y) 7.6% 10.9% 12.6%
Operating income growth (1Y) 27.3% 206.4% 13.6%
Operating income CAGR (3Y) 16.1% 2.4% 63.6%
Net income growth (1Y) 28.5% 2,369% 13.6%
Net income CAGR (3Y) 14.2% 8.6% 86.5%
EPS growth (1Y) 24.2% 2,213% 16.9%
EPS CAGR (3Y) 15.9% 8.5% 90.8%
Operating cash flow growth (1Y) 9.3% 105.4% 11.6%
Operating cash flow CAGR (3Y) 15.2% 9.9% 18.7%
Free cash flow growth (1Y) 11.8% 147.4% 10.1%
Free cash flow CAGR (3Y) 16.3% 11.3% 19.9%

Profitability

14 metrics
MetricMCKCVSCAH
Gross margin 3.7% 44.2% 3.9%
EBITDA margin 1.8% 4.7% 1.4%
Operating margin 1.6% 3.6% 1.0%
Pretax margin 1.6% 2.9% 0.9%
Net margin 1.1% 2.6% 0.7%
FCF margin 1.7% 3.7% 1.9%
Operating cash flow margin 1.8% 4.4% 2.2%
Return on equity – 13.8% –
Return on assets 6.0% 4.3% 3.1%
Return on invested capital 98.7% 9.7% 36.5%
Return on capital employed 42.0% 9.2% 22.3%
Asset turnover 4.6x 1.6x 4.4x
Cash conversion (OCF / net income) 1.4x 1.7x 3.1x
Stock comp / revenue – 0.2% 0.1%

Financial Health

11 metrics
MetricMCKCVSCAH
Debt / assets 10.0% 23.5% 14.8%
Debt / equity -2.3x 0.8x -2.9x
Net debt / EBITDA 0.4x 2.3x 1.0x
Debt / FCF 1.3x 3.9x 1.8x
Liabilities / assets 104.3% 68.7% 105.1%
Equity / assets -4.3% 31.3% -5.1%
Interest coverage 21.9x 4.9x 7.9x
Current ratio 0.9x 0.9x 0.9x
Quick ratio 0.5x 0.8x 0.4x
Cash ratio 0.1x 0.2x 0.1x
Altman Z-score 5.83 2.51 5.05

Shareholder Returns

7 metrics
MetricMCKCVSCAH
Dividend yield 0.3% 3.0% 0.7%
Net buyback yield 5.2% -0.4% 2.3%
Shareholder yield 5.6% 2.6% 3.0%
Payout ratio (earnings) 7.4% – 26.8%
Payout ratio (FCF) 5.6% – 10.0%
Dividend growth (1Y) 10.5% – -1.4%
Dividend CAGR (3Y) 9.8% – -1.7%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKCVSCAH
Forward P/E 22.8xFY2026 10.2xFY2026 22.8xFY2027
EPS, next fiscal year $48.34FY2026 $8.80FY2026 $12.31FY2027
EPS growth, next FY +23.6%FY2026 +30.4%FY2026 +9.3%FY2027
EPS growth, the year after +11.9% +1.1% +12.8%
Revenue, next fiscal year $447.65BFY2026 $431.16BFY2026 $273.40BFY2027
Revenue growth, next FY +11.0%FY2026 +7.2%FY2026 +7.5%FY2027
Revenue growth, the year after +1.5% -5.3% -3.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKCVSCAH
Held by institutions 89.1% 89.1% 87.4%
Institutions holding 2,014 2,074 1,494
Change in shares held, QoQ -0.7% +3.5% +2.8%
Institutions buying 883 1,103 711
Institutions selling 793 733 559
Buyers to sellers 1.11 1.50 1.27

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKCVSCAH
MCK 1.00 0.02 0.73
CVS 0.02 1.00 0.11
CAH 0.73 0.11 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, CVS and CAH?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $128.85B, Cvs Health (CVS) $113.39B, Cardinal Health (CAH) $65.94B.

Which stock is cheaper, MCK, CVS and CAH?

Cvs Health (CVS) trades on the lowest price-to-earnings ratio (Mckesson (MCK) 27.4x, Cvs Health (CVS) 10.3x, Cardinal Health (CAH) 36.3x). On next year's consensus earnings, Cvs Health (CVS) is cheapest (Mckesson (MCK) 22.8x, Cvs Health (CVS) 10.2x, Cardinal Health (CAH) 22.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Cardinal Health (CAH) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.2%, Cvs Health (CVS) +6.7%, Cardinal Health (CAH) +10.0%.

Which company is more profitable?

Cvs Health (CVS) has the highest net margin (Mckesson (MCK) 1.1%, Cvs Health (CVS) 2.6%, Cardinal Health (CAH) 0.7%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 98.7%, Cvs Health (CVS) 9.7%, Cardinal Health (CAH) 36.5%).

Which stock has performed better?

Over the past year Cardinal Health (CAH) returned the most: Mckesson (MCK) +30.3%, Cvs Health (CVS) +12.7%, Cardinal Health (CAH) +36.4%. Over five years, Cardinal Health (CAH) compounded fastest (Mckesson (MCK) +37.5%/yr, Cvs Health (CVS) -1.0%/yr, Cardinal Health (CAH) +40.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Cardinal Health (CAH) has the highest dividend yield: Mckesson (MCK) 0.00%, Cvs Health (CVS) 0.00%, Cardinal Health (CAH) 0.01%. Cvs Health (CVS) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cardinal Health (CAH) has been the steadiest (Mckesson (MCK) 31.4%, Cvs Health (CVS) 35.1%, Cardinal Health (CAH) 25.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, CVS and CAH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cardinal Health (CAH) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.